Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: Evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin α(IIb)β3

Blood

Volumn 89, Issue 12, 1997, Pages 4385-4392

  Rosa, Jean Philippe ^a   Artçanuthurry, Valérie ^a   Grelac, Françoise ^a   Maclouf, Jacques ^a   Caen, Jacques P ^a   Lévy Toledano, Sylviane ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; CORTACTIN; CYTOSKELETON PROTEIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CONTROLLED STUDY; GLANZMANN DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 1842337448     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4385     Document Type: Article

References (29)

1. Golden A, Brugge JS: Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc Natl Acad Sci USA 86:901, 1989
2. Ferrell JE, Martin GS: Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. Proc Natl Acad Sci USA 86:2234, 1989
3. Golden A, Brugge JS, Shattil SJ: Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. J Cell Biol 111:3117, 1990
4. Shattil SJ, Ginsberg MH, Brugge JS: Adhesive signaling in platelets. Curr Opin Cell Biol 6:695, 1994
5. Clark EA, Shattil SJ, Brugge JS: Regulation of protein tyrosine kinases in platelets. Trends Biochem Sci 19:464, 1994
6. 3. J Biol Chem 269:28859, 1994
7. Fox JEB, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS: On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton. J Biol Chem 268:25973, 1993
8. 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125 FAK. J Cell Biol 122:473, 1993
9. Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parsons JT, Brugge JS: Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 119:905, 1992
10. Nurden AT, Caen JP: An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol 28:253, 1974
11. George JN, Nurden AT: Inherited disorders of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier Syndrome and other disorders, in Coleman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 652
12. Phillips DR, Charo IF, Parise LV, Fitzgerald LA: The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831, 1988
13. Bray PF: Inherited diseases of platelet glycoproteins: Considerations for rapid molecular characterization. Thromb Haemost 72:492, 1994
14. Caen JP: Glanzmann thrombasthenia, in O'Brien JR (ed): Clinics in Hematology: Platelet Disorders (ed 2). London, UK, Saunders, 1972, p 283
15. Lee H, Nurden AT, Thomaidis A, Caen JP: Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II. Br J Haematol 48:47, 1981
16. Djaffar I, Caen JP, Rosa J-P: A large alteration in the human platelet glycoprotein IIIa (integrin beta 3) gene associated with Glanzmann's thrombasthenia. Hum Mol Genet 2:2183, 1993
17. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann's thrombasthenia. Proc Natl Acad Sci USA 89:10169, 1992
18. Rendu F. Maclouf J, Launay JM, Boinot C, Levy-Toledano S, Tanzer J, Caen J: Hermansky-Pudlak platelets: Further studies on release reaction and protein phosphorylations. Am J Hematol 25:165, 1987
19. Blanco A, Habib A, Levy-Toledano S, Maclouf J: Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem J 312:419, 1995
20. Plow EF, D'Souza SE, Ginsberg MH: Ligand binding to GPIIb-IIIa: A status report. Semin Thromb Hemost 18:324, 1992
21. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 72:325, 1983
22. syk to the cytoskeleton in thrombin-stimulated platelets. J Biol Chem 269:32796, 1994
23. syk activation in human platelets stimulated with collagen is dependent upon glycoprotein Ia/IIa and actin polymerization. Thomb Haemost 75:648, 1996
24. 3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem 271:7004, 1996
25. Ozawa K, Kashiwada K, Takahashi M, Sobue K: Translocation of cortactin (p80/85) to the actin-base cytoskeleton during thrombin receptor-mediated platelet activation. Exp Cell Res 221:197, 1995
26. Okamura H, Resh MD: p80/85 cortactin associates with the src SH2 domain and colocalizes with v-src in transformed cells. J Biol Chem 270:26613, 1995
27. Maruyama S, Kurosaki T, Sada K, Yamanashi Y, Yamamoto T, Yamamura H: Physical and functional association of cortactin with Syk in human leukemic cell line K562. J Biol Chem 271:6631, 1996
28. syk without inducing platelet activation. J Biol Chem 271:26547, 1996
29. Frangioni JV, Oda A, Smith M, Salzman EW, Neel BG: Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 12:4843, 1993